PP113 Reimbursement Of Oncology Therapies With Limited Clinical Evidence In The Netherlands
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Technology Assessment in Health Care"
DOI: 10.1017/s0266462322002367
Abstract: Introduction The number of novel therapies that achieve registration in oncology based on limited clinical evidence like non-randomized studies (NRS) is increasing. Dutch health authorities determine the therapeutic value of medicines evaluated in randomized controlled… read more here.
Keywords: oncology; clinical evidence; oncology therapies; evidence ... See more keywords